Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Brennand

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Psychiatry|April 5, 2012
Modeling psychiatric disorders at the cellular and network levelsK J Brennand, A Simone, N Tran, et al.
Molecular and Cellular Neurosciences|May 28, 2017
Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric diseaseS K Powell, J Gregory, S Akbarian, et al.
Schizophrenia Research|January 18, 2017
Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS)S T Narla, Y-W Lee, C A Benson, et al.
Translational Psychiatry|November 18, 2018
Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1E K Stachowiak, C A Benson, S T Narla, et al.
Molecular Psychiatry|January 25, 2017
MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in miceA C Mitchell, B Javidfar, V Pothula, et al.
Translational Psychiatry|October 21, 2015
Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patientsA Topol, J A English, E Flaherty, et al.
Molecular Psychiatry|October 19, 2016
Inhibition of STEP<sub>61</sub> ameliorates deficits in mouse and hiPSC-based schizophrenia modelsJ Xu, B J Hartley, P Kurup, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Psychiatry|April 5, 2012
Modeling psychiatric disorders at the cellular and network levelsK J Brennand, A Simone, N Tran, et al.
Molecular and Cellular Neurosciences|May 28, 2017
Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric diseaseS K Powell, J Gregory, S Akbarian, et al.
Schizophrenia Research|January 18, 2017
Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS)S T Narla, Y-W Lee, C A Benson, et al.
Translational Psychiatry|November 18, 2018
Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1E K Stachowiak, C A Benson, S T Narla, et al.
Molecular Psychiatry|January 25, 2017
MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in miceA C Mitchell, B Javidfar, V Pothula, et al.
Translational Psychiatry|October 21, 2015
Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patientsA Topol, J A English, E Flaherty, et al.
Molecular Psychiatry|October 19, 2016
Inhibition of STEP<sub>61</sub> ameliorates deficits in mouse and hiPSC-based schizophrenia modelsJ Xu, B J Hartley, P Kurup, et al.
Pageof 1